Taxol and taxotere—Current status and future prospects
- 31 December 1993
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (9), 1228-1231
- https://doi.org/10.1016/0959-8049(93)90062-k
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Taxol: Twenty Years Later, the Story UnfoldsJNCI Journal of the National Cancer Institute, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compoundsGynecologic Oncology, 1990
- Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron, 1989
- Vincristine infusion in refractory gynecologic malignanciesGynecologic Oncology, 1986
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Promotion of microtubule assembly in vitro by taxolNature, 1979
- Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifoliaJournal of the American Chemical Society, 1971